0001209191-16-119300.txt : 20160511 0001209191-16-119300.hdr.sgml : 20160511 20160511184141 ACCESSION NUMBER: 0001209191-16-119300 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160502 FILED AS OF DATE: 20160511 DATE AS OF CHANGE: 20160511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neothetics, Inc. CENTRAL INDEX KEY: 0001618835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208527075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: (858) 750-1008 MAIL ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270 CITY: SAN DIEGO STATE: CA ZIP: 92122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Feldman Maria CENTRAL INDEX KEY: 0001674083 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36754 FILM NUMBER: 161641213 MAIL ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270 CITY: SAN DIEGO STATE: CA ZIP: 92122 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-05-02 0 0001618835 Neothetics, Inc. NEOT 0001674083 Feldman Maria 9171 TOWNE CENTRE DRIVE, SUITE 270 SAN DIEGO CA 92122 0 1 0 0 VP Clinical Research & Opera Stock Option (Right to Buy) 1.342 2024-03-10 Common Stock 21498 D Stock Option (Right to Buy) 6.79 2025-02-10 Common Stock 14727 D Stock Option (Right to Buy) 6.79 2025-02-10 Common Stock 3273 D Stock Option (Right to Buy) 0.9701 2026-02-04 Common Stock 25000 D Twenty-five (25%) of the option shares shall vest on the one (1) year anniversary from the vesting commencement date March 1, 2014, and the option shares shall vest in in thirty-six (36) equal monthly installments thereafter, subject to the reporting person continuing to be a service provider to the issuer through each vesting date. Option shares shall vest in forty-eight (48) equal monthly installments from the vesting commencement date February 10, 2015, subject to the reporting person continuing to be a service provider to the issuer through each vesting date. Option shares shall vest in forty-eight (48) equal monthly installments from the vesting commencement date February 4, 2016, subject to the reporting person continuing to be a service provider to the issuer through each vesting date. Exhibit 24 - Power of Attorney /s/ Maria Feldman 2016-05-11 EX-24.3_653470 2 poa.txt POA DOCUMENT POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Susan Knudson, individually, their true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or 10% or greater stockholder of Neothetics, Inc. (the "Company"), any and all Form 3, 4 and 5 reports required to be filed by the undersigned in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 report and timely file such report with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned, pursuant to this Power of Attorney, shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in her discretion. The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform each and every act and thing whatsoever requisite, necessary, and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or her substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that no such attorney-in-fact, in serving in such capacity at the request of the undersigned, is hereby assuming, nor is the Company hereby assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Form 3, 4 and 5 reports with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 5th day of May, 2016. Signature /s/ Maria Feldman Print Name